Author: Garg, Nikita; McClafferty, Brendan; Ramgobin, Devyani; Golamari, Reshma; Jain, Rahul; Jain, Rohit
Title: Cardiology and COVID-19: do we have sufficient information? Cord-id: zt21qic4 Document date: 2020_10_30
ID: zt21qic4
Snippet: Novel coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2, which originated in Wuhan (China), transformed into a worldwide pandemic. The short span associated with the spread of the virus and its varied manifestations presents a steep learning curve for many clinicians on the front-line of treatment. Cardiology is one such affected area. This paper details the signs and symptoms of cardiovascular disease resulting from COVID-19, including its proposed pa
Document: Novel coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2, which originated in Wuhan (China), transformed into a worldwide pandemic. The short span associated with the spread of the virus and its varied manifestations presents a steep learning curve for many clinicians on the front-line of treatment. Cardiology is one such affected area. This paper details the signs and symptoms of cardiovascular disease resulting from COVID-19, including its proposed pathophysiology, signs and symptoms, treatments and outcomes under investigation. The consensus is that COVID-19 patients with cardiovascular injury have a shorter duration from symptom onset to deterioration, higher mortality and higher prevalence in older populations. Diagnosis and intervention for patients with underlying cardiovascular comorbidities is critical.
Search related documents:
Co phrase search for related documents- ace inhibitor angiotensin receptor blocker and acute cardiac injury: 1
- ace inhibitor angiotensin receptor blocker and acute coronary syndrome: 1
- ace inhibitor angiotensin receptor blocker and acute kidney injury: 1, 2, 3
- ace inhibitor angiotensin receptor blocker and acute respiratory distress syndrome: 1, 2, 3
- ace inhibitor angiotensin receptor blocker and admission icu intensive care unit: 1, 2, 3
- acute ards respiratory distress syndrome and admission icu intensive care unit: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
- acute ards respiratory distress syndrome and low molecular: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
- acute ards respiratory distress syndrome and low molecular unfractionated heparin: 1
- acute ards respiratory distress syndrome and low molecular unfractionated heparin weight heparin: 1
- acute ards respiratory distress syndrome and low molecular weight heparin: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- acute ards respiratory distress syndrome and lung affect: 1, 2, 3, 4, 5, 6
- acute ards respiratory distress syndrome and macrophage infiltration: 1, 2
- acute cardiac injury and admission icu intensive care unit: 1, 2, 3, 4, 5, 6, 7, 8, 9
- acute cardiac injury and lung affect: 1, 2
- acute coronary syndrome and admission icu intensive care unit: 1, 2
- acute coronary syndrome and low molecular: 1, 2, 3, 4
- acute coronary syndrome and low molecular unfractionated heparin: 1
- acute coronary syndrome and low molecular weight heparin: 1, 2, 3, 4
- acute illness and admission icu intensive care unit: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
Co phrase search for related documents, hyperlinks ordered by date